FDA Brief

Warning letters Biologics

FDA warning letter to

Konrad Rejdak, M.D., Ph.D.

Issued May 29, 2024Posted Aug 13, 2024Center for Biologics Evaluation and Research (CBER)

Bioresearch Monitoring Program/IRB. We haven't summarized this letter yet. Read it on fda.gov.